Risk stratification in pediatric celiac disease

AJBM crossMark

Mark C. Wakeman, Peter A. Slavin, Ronaldo T. Gismondi¹*

Abstract

A 6-year-old white girl with a longstanding history of severe constipation who was referred for suspected Irritable Bowel Syndrome. Instead, serologies showed all three of these tests to be markedly positive for tissue transglutaminase. IgA endomysial antibody was also positive, though testing of total immunoglobulin A and HLA did not show increased risk on repeat levels. After several routine consultations, a duodenal biopsy was performed and her Marsh score was 2 (intraepithelial lymphocytosis only). Given the discordance between her symptoms and her biopsy as well as persistently high titers of antibodies since beginning a gluten-free diet, a repeat biopsy was performed over 4 years later. Patient re-attended clinic at ten years of age. On repeat endoscopy, she had changes consistent with increased intraepithelial lymphocytosis and maleylation (Villa score of 1b), a score lower than at her initial duodenal biopsy: Marsh 1 (inflammation) instead of Marsh 0 (normal). While it is atypical to have duodenal lymphocytosis alone represent symptomatic celiac, in this case the evidence warranted a diagnosis of celiac disease (with hyperplastic lymphocytosis representing early endoscopic changes). Her anti-tTG was always significantly elevated as well as the EMA. It should be noted that initial biopsies are not available for CD3+ staining to look for lymphocytosis alone at her original presentation. However, this article discusses her presentation and diagnosis in the context of the risk stratification theme of this Special Issue. Bloating or swelling (Q1 for Gastrointestinal-Irritable Bowel Syndrome), Seek medical care for abdominal swelling (Q2 for Gastrointestinal-Irritable Bowel Syndrome), Abdominal tenderness (Q3 for Gastrointestinal-Irritable Bowel Syndrome), Take medication for abdominal pain (Q5 for Gastrointestinal-Irritable Bowel Syndrome) were all rated in the negative, consistent with the diagnosis of celiac disease on the CHOP Modified-Fickie.

Keywords: Celiac disease; Gluten; Immune system

Copyright © 2019 by The American Society for BioMedicine and BM-Publisher, Inc.

Article citationReferencesFeedback
The citation data is computed by the following citation measuring services:

Google scholarcitedby

  1. Thompson T, Lee AR, Grace T. Gluten contamination of grains, seeds, and flours in the United States: a pilot study. J Am Diet Assoc 2010;110:937. [Medline]
  2. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:1. [Medline]
  3. Fasano A, Araya M, Bhatnagar S, et al. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr 2008;47:214. [Medline]
  4. Troncone R, Auricchio S. Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J Pediatr Gastroenterol Nutr. 2007 May. 44(5):527-8. [PubMed]
  5. Bonamico M, Mariani P, Thanasi E, et al. Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004;38(2):204-7. [PubMed]
  6. Sharma A, Mews C, Jevon G, Ravikumara M. Duodenal bulb biopsy in children for the diagnosis of coeliac disease: Experience from Perth, Australia. J Paediatr Child Health 2013;22. [PubMed]
  7. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40(1):1-19. [PubMed]
  8. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131(6):1981-2002. [PubMed]
  9. Barbato M, Maiella G, Di Camillo C, et al. The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea. Dig Liver Dis 2011;43(6):465-9.
  10. Giersiepen K, Lelgemann M, Stuhldreher N, et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 205;54(2):229-41. [PubMed]
  11. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009;136(3):816-23. [PubMed]
  12. Akobeng AK, Thomas AG. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 20027(11):1044-52. [PubMed]
  13. Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 201;105(6):1412-20. [PubMed]
  14. Diamanti A, Ferretti F, Guglielmi R, et al. Thyroid autoimmunity in children with coeliac disease: a prospective survey. Arch Dis Child 2011;96(11):1038-41. [PubMed]
  15. Leffler DA, Dennis M, Edwards GJ, et al. A Simple Validated Gluten-Free Diet Adherence Survey for Adults With Celiac Disease. Clin Gastroenterol Hepatol 2009;11.
  16. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54(1):136-60.
  17. Isselbacher KJ, Braunwald E, Wilson JD. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw Hill;1994. 1398-400.
  18. Kelly CP, Green PH, Murray JA, et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013;(2):252-62. [PubMed]
  19. Kondrashova A, Mustalahti K, Kaukinen K, et al. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med 2008;40(3):223-31. [PubMed]
  20. Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S. Diagnosis of celiac disease. Gastrointest Endosc Clin N Am 2012; 22(4):661-77. [PubMed]
  21. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. St Louis, MO: Mosby;1990; 1277-80.
  22. Panetta F, Torre G, Colistro F, Ferretti F, Daniele A, Diamanti A. Clinical accuracy of anti-tissue transglutaminase as screening test for celiac disease under 2 years. Acta Paediatr 2011;100(5):728-31. [Medline]
  23. Saltzman JR, Russell RM. The aging gut. Nutritional issues. Gastroenterol Clin North Am 1998;27(2):309-24. [PubMed]
  24. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-911.
  25. Collin P, Thorell L, Kaukinen K, Mäki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004;19:1277. [Medline]
  26. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136. [Medline]

Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...

Find out more

Topic Review


DOI: http://dx.doi.org/10.18081/2333-5106/016-2/75-85
American Journal of BioMedicine Volume 7, Issue 2, pages 50-63
Received November 14, 2018; Accepted March 11, 2019; Published April 13, 2019

How to cite this article
Wakeman MC, Slavin PA, Gismondi RT. Risk stratification in pediatric celiac disease. American Journal of BioMedicine 2019;7(2):50-63.

Article outline
1. Abstract
2. Keywords
3. Introduction
4. Discussion
7. Acknowledgements
8. References